Business ❯ Healthcare

Drug Development

Clinical Trials Market Competition Incretin Medications Acquisitions Biosimilars Market Performance Biosimulation FDA Approvals Collaboration Pharmaceuticals Generic Drugs Immunotherapy Therapeutics Cancer Treatment Patent Issues Eli Lilly Clinical Research Innovative Drugs New Products Genetic Conditions Selinexor Sales Milestones Artificial Intelligence

Viking Therapeutics Rallies as Weight‑Loss Program Moves Toward Late‑Stage Testing

Pivotal Phase 3 readouts for injectable and oral VK2735 are expected in 2027 and 2028.

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Simulations Plus Beats Q2, Lowers FY2026 Profit Outlook

Karyopharm Raises $30 Million in RA Capital Private Placement

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Novo’s Wegovy Pill Posts Quick Uptake, Boosting Shares as Oral GLP‑1 Battle Nears

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

Novo Nordisk Freezes Hiring as Layoffs Loom in GLP-1 Retrenchment